Open Access
MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial
European Journal Of EndocrinologyPeer ReviewedLine Velling Magnussen +82017Journals
Men with type 2 diabetes mellitus (T2D) often have lowered testosterone levels and an increased risk of cardiovascular disease (CVD). Ectopic fat increases the risk of CVD, whereas subcutaneous gluteofemoral fat protects against CVD and has a beneficial adipokine-secreting profile.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support